Aurobindo Pharma

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue2,5252,9472,9712,8462,932
Expenses2,0792,2242,3382,2902,182
EBITDA564.25843.54767.41710.49880.11
EBIT497.37775.38699.13616.61810.09
Profit Before Tax446.24723.75632.94555.52750.09
Net Profit329.04537.53472.05408.17559.13
Financial Ratios
Operating Profit Margin23.27%30.59%26.61%26.11%31.19%
Net Profit Margin13.57%19.49%16.37%15.00%19.81%
Earning Per Share (Diluted)5.629.218.137.039.63
Dividends Per Share0.000.000.000.000.00